日本医科大学医学会雑誌
Online ISSN : 1880-2877
Print ISSN : 1349-8975
ISSN-L : 1349-8975
原著
切除不能進行再発胃癌に対するS-1+シスプラチン療法の有害事象対策と外来化学療法
前島 顕太郎谷合 信彦吉田 寛
著者情報
ジャーナル フリー

2019 年 15 巻 3 号 p. 128-133

詳細
抄録

Although S-1+cisplatin therapy is used as first-line therapy for unresectable progressive/recurrent gastric cancer, the incidence of adverse events is not low. Renal dysfunction, especially, is an important side effect of dose-limiting toxicity and requires caution. Conversely, outpatient chemotherapy is becoming popular nationwide, but at the time of cisplatin administration, it is burdensome for patients to be infused for hospitalization to prevent renal dysfunction. It is possible that there is no difference between the incidence of renal dysfunction in patients to whom cisplatin is administered during hospitalization and that in outpatients treated with a short hydration regimen. Furthermore, currently, because of the increase in the infusion speed and use of magnesium, data on renal dysfunction associated with cisplatin administration in outpatient settings have not been reported. Here we report a case of the onset of renal dysfunction.

著者関連情報
© 2019 日本医科大学医学会
前の記事 次の記事
feedback
Top